1-7 of 7
Nicole Engel-Nitz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The first characterization of disease burden and healthcare resource utilization for the recent definition of severe von Willebrand disease using a large United States real-world dataset

Free
Angela Weyand, Michelle Sholzberg, Laura Guido, Jacob Lai, Nicole Engel-Nitz, Qiana Amos, Robert Sidonio, Jr.
Journal: Blood
Blood (2025) 146 (Supplement 1): 2611.
https://doi.org/10.1182/blood-2025-2611
Published: 2025
Journal Articles

Impact of ruxolitinib on corticosteroid treatment patterns in 1147 patients with chronic graft-versus-host disease in real-world practice in the United States: A long-term follow-up analysis

Free
Jingbo Yu, Nicole Engel-Nitz, Mary DuCharme, Jordan Fortunato, John Galvin, Valkal Bhatt, Catherine Lee
Journal: Blood
Blood (2025) 146 (Supplement 1): 2452.
https://doi.org/10.1182/blood-2025-2452
Published: 2025
Journal Articles

Real-world characteristics and treatment patterns in patients with essential thrombocythemia by thrombosis risk levels

Free
Helmneh Sineshaw, Yong Zhu, Nicole Engel-Nitz, Lisa Le, Nati Lerman
Journal: Blood
Blood (2025) 146 (Supplement 1): 3811.
https://doi.org/10.1182/blood-2025-3811
Published: 2025
Journal Articles

Incidence, prevalence, and clinical outcomes of myelofibrosis with and without cytopenia in the United States

Free
Aaron Gerds, Lindsay Rein, Nicole Engel-Nitz, Michael Marrone, Jeffrey McPheeters, Abiola Oladapo, Purvi Suthar, Michael Vredenburg, Yong Zhu, Lucia Masarova
Journal: Blood
Blood (2025) 146 (Supplement 1): 5576.
https://doi.org/10.1182/blood-2025-5576
Published: 2025
Journal Articles

Persistence of Enrollment Among Commercial Enrollee Populations with Rare Hematologic Diseases: Implications for Long-Term Outcome Assessment and Value-Based Agreements

Free
Michelle Vu, Rui Song, Nicole Engel-Nitz, Erin Hulbert
Journal: Blood
Blood (2022) 140 (Supplement 1): 13174–13175.
https://doi.org/10.1182/blood-2022-156602
Published: 2022
Journal Articles

What Is the Cost of Disease Progression Among Patients with Indolent or Aggressive Non-Hodgkin Lymphoma (NHL)?

Free
Nicole Engel-Nitz, PhD, Stacey Dacosta Byfield, PhD MPH, Timothy Bancroft, PhD, Anderson J. Amy, M.S., Carolina Reyes, PhD, May Chen, MD, Matthew J. Matasar, MD MS
Journal: Blood
Blood (2016) 128 (22): 5957.
https://doi.org/10.1182/blood.V128.22.5957.5957
Published: 2016
Journal Articles

Differences in Patients with Progressive Versus Non-Progressive AML, CLL, or NHL: Implications for Proposed Bundled Payment Strategies

Free
Stacey Dacosta Byfield, PhD MPH, Nicole Engel-Nitz, PhD, Timothy Bancroft, PhD, Amy J Anderson, MS, Carolina Reyes, PhD, Arliene Ravelo, MPH, Sarika Ogale, PhD, May Chen, MD, Matthew J. Matasar, MD MS
Journal: Blood
Blood (2015) 126 (23): 4528.
https://doi.org/10.1182/blood.V126.23.4528.4528
Published: 2015